The Salina Journal from Salina, Kansas on October 10, 1996 · Page 7
Get access to this page with a Free Trial

The Salina Journal from Salina, Kansas · Page 7

Salina, Kansas
Issue Date:
Thursday, October 10, 1996
Page 7
Start Free Trial

THURSDAY OCTOBER 10, 1996 THE SAUNA JOURNAL BRIEFLY Parents, be alert for strep throat symptoms v NEW YORK - This is the time of year when parents should be alert for the symptoms that indicate a child has a streptococcal infection — strep throat. Any child who develops a fever aM sore throat should be taken to a physician for diagnosis, and treatment if necessary. Fever and sore throat symptoms sometimes are accompanied by headache, muscle pain and other indicators of infection. But fever and sore throat are the major warning signs of strep throat. Untreated or undertreated strep throat can lead to rheumatic fever, which can cause permanent heart damage. Strep throats occur all year- round but are less frequent during the summer months. Stroke risk doubles after pregnancy BOSTON — A woman's risk of stroke doubles — but is still extremely small — during the six Weeks after she delivers a baby, a study found. Doctors have long noticed a link between childbearing and strokes. But the new study found that contrary to common belief, the hazard increases just after delivery, not during pregnancy itself. : Since strokes are so unusual in young women, the actual number after pregnancy is still small. The researchers estimate that there might be eight more strokes than vfrould otherwise be expected for every 100,000 women in the period immediately after pregnancy. I Just why this happens is unknown, although the doctors speculate that hormonal changes are somehow involved. Older may be better in the workplace f NEWARK, Ohio — Working older widows tend to occupy the lower rungs of the pay scale, but, according to a study, they report more pleasurable experiences than hassles at work. • Although widows in a recent . sludy tended to have less education and lower salaries, they felt that they were most effective at work at a later age than did other workers. They enjoyed contact With people and an opportunity to bjelp others. "Even though older widows may seem at a disadvantage because they earn less than others, they still get a great deal of satisfaction from their work," said Sara Staats, psychology professor at Ohio State University, who conducted the study. ^Their only complaints centered around negative people and interruptions in the workplace. .It's important to understand the work experiences of older women such as this because they are a rapidly growing — and little understood — segment of the workforce. Latin lovers line up for tummy tucks ROME — The "Baywatch mentality" has taken hold in Italy and Spain. Latin lovers are patronizing plastic surgeons in increasing numbers, most often for paunch removal. ; Dr. Anna Zanetti, a plastic surgeon in both countries, revealed that the number of Latin men using cosmetic surgery is soaring. 1 "My experience over the past seven years is the ratio of men to wpmen has gone from around one ui 20 to one in four," she said. Other favorites are anti-cellulite treatments, remodeling lips with collagen or silicone and "peeling" to rejuvenate facial skin. .Zanetti said the obsession with "belia figura" is stronger among Spaniards. "The slightest defect is enough to send them hurrying to a cosmetic surgeon." From Wire Service Reports f HEARTBURN CURE Health DR. DONOHUE / C2 MONEY / C3 CLASSIFIED / C6 c During training, the biopsy procedure Is simulated by a bell pepper filled with biscuit dough and a crushed calcium pill, then enclosed In a surgical glove. Diagnosing Breast Cancer Salina hospital's biopsy unit quickly pinpoints suspicious tissue without major surgery Photos by DAVIS TURNER/The Salina Journal Subdued lighting and peaceful music set the tone in Salina Regional Health Center's radiology department where a new stereotactic core breast biopsy unit is now available on the Penn Campus. Two radiology technicians, Shell! Horyna (left) and JoLinda Rains, look over a computer-generated X-ray next to the biopsy table. The latest diagnostic procedure, which requires only a local anesthetic, Is more accurate and less Invasive than traditional breast biopsies. Radiology technician JoLinda Rains practices the extraction of sample tissue from the machine's hollow needle. During an actual procedure, the patient's breast protudes through the round opening in the table. By GORDON D. FIEDLER JR. The Salina Journal When a mammogram detects a suspicious lump, women have basically one option to learn if the questionable tissue is cancerous: major surgery. Beginning today, Salina Regional Medical Center offers women an alternative to open surgery: breast biopsies. Proponents of the new procedure say it's less costly, results in less scarring and deformity and is as accurate as traditional surgery. Called a stereotactic core breast biopsy, the new equipment is able to pinpoint suspect masses with greater accuracy, allowing doctors to extract smaller amounts of tissue. "It can tell us within one millimeter where the lesion is," said Salina radiologist Dr. Bill Garlow. With the machine, doctors need only a three-millimeter incision to insert a needle-like device about half the diameter of a drinking straw that harvests a half-inch-long sample. "You have minimal scaring outside the breast, plus it doesn't disrupt as much tissue inside," said radiologist Dr. Ray House. In addition, patients receive a local anesthetic. A standard open surgery biopsy, requiring general anesthesia, removes a mass of tissue about the size of a walnut or lemon. Yet, this new equipment doesn't eliminate the need for a mammogram and still requires the often uncomfortable compression of the breast. Monthly self- examinations remain the first line of defense in detecting abnormalities, according to the American Cancer Society. In addition to self-exams, the society recommends doctor's exams every several years for women in their 20s and 30s, annual mammograms for women starting at age 40, and two a year starting at age 50. Breast cancer statistics • Breast cancer strikes 1 in every 9 women. • Nationally, it's the leading cause of death of women between the ages of 55 and 74. • It was the most commonly diagnosed cancer last year in Salina. •Locally, 250 breast biopsies were performed in 1995. Of those, 148 were benign. Any lump or thickening should be checked by a doctor, who may prescribe a mammogram, which is an X-ray glimpse of breast tissue. Part of the new biopsy device allows close-up enlargements of specific breast areas rather than the single view of traditional mammography equipment. The biopsy unit itself resembles a padded examination table with a hole near one end through which the breast extends. A special X-ray camera records stereo-optic views of the suspect area depicted in the mammogram. The image is immediately displayed on a computer monitor. There's no need to wait for X-ray film to develop. The computer gives doctors precise coordinates of the lesion, information they use to guide the needle to the mass. The procedure is finished in an hour or less and costs, generally, about a third of open surgery biopsies, which average between $2,500 and $5,000. "The women can usually go back to work the following day," House said. The number of breast biopsies performed in Salina in 1995 suggests a need for a less-invasive procedure. Of 250 biopsies, 148 were benign. "The minimum invasiveness of it is the clear advantage," House said. V WOMAN'S HEALTH Patients find more treatment options FREDRIC D. FRIGOLETTO JR. OB/GWV There are reasons to be optimistic about the recent progress in our understanding and treatment of breast cancer. This is a survivor's disease. When detected in early stages, breast cancer is nearly always survivable. For localized tumors found early, the survival rate is up to 95 percent. Screening can work. Regular mammograms for women age 50 and older reduce breast cancer mortality by about one-third. At age 40, a reduction also occurs but is somewhat lower. In the past decade, the average size of discovered tumors has been shrinking (to 2.17 centimeters in 1991) — suggesting early detection can make a difference. Many states now require insurers to offer coverage of breast cancer screening. Treatment options are increasing. We now know that lumpectomy plus radiation therapy is as effective as mastectomy for treating early cancers, reducing the need for disfiguring surgery. Breast reconstruction also is being perfected for those who undergo mastectomy. Adjuvant drug therapy (chemotherapy combined with surgery) improves survival rates, even for women at only moderate risk for spread of the disease. For more advanced cancer, chemotherapy following mastectomy has been found more effective than mastectomy alone. A new drug, taxol, is being tested in clinical trials. Bone marrow transplant The new technique of bone marrow transplant, while investigational, offers hope for some patients with advanced disease. Some insurers have agreed to cover this therapy on a case-by-case basis. We are making rapid advances. Scientists are closer to predicting where breast cancer will strike and how fast it will spread. Two newly discovered genetic mutations (BRCA1 and BRCA2) appear to be responsible for at least 80 percent of all inherited breast cancer. Heredity accounts for only about five percent of all breast cancer. Investigators are tracking biochemical "markers" associated with cancer cell growth, and these will help us eventually to predict the course of the disease in each patient. These recent advances in our knowledge suggest that we are making significant progress in our understanding, treatment — and possible prevention — of breast cancer. peptic ulcer vaccine threatens popular drugs By Scrlpps Howard News Service ' • * STOCKHOLM, Sweden — Oravax, a small IJF.S. biotechnology group, will unveil a vaccine next week which it claims could almost eliminate the market for peptic ulcer treatments. Mf successftu, the vaccine could severely hit multimillion-dollar sales of the world's two best- selling drugs, Glaxo's Zantac and Astra's Losec. Massachusetts-based Oravax received a U.S. patent for the drug this year and is optimistic it will come to market by 2001. Losec's patents begin to expire in 2000, and Zantac's begin to expire next July. Oravax said the vaccine, which is being developed with Pasteur Merieux Connaught, a subsidiary of Rhone-Poulenc, the French chemicals and drugs group, neutralizes the bacterium helicobacter pylori. The bacterium causes most peptic ulcers, as well as gastric reflux, chronic heartburn and even bad breath and acne. The bacterium has also been linked with stomach cancer. About 50 percent of the world's population carries the bacterium. Company president Lance Gordon said the agent would cure and prevent ulcers. He predicted it would supersede Losec in the peptic ulcer market, which accounts for 5-10 percent of Losec's sales. "It will come close to elimi- nating the need for peptic ulcer management," he said. Data on the vaccine will be presented at a conference in Copenhagen next week. Astra's Losec generated first half sales of $2.16 billion and Glaxo's Zantac $1.63 billion. Astra, of Sweden, insisted the vaccine would have no foreseeable impact on Losec, although it conceded there might be long-term implications. The vaccine is currently in effectiveness trials. Astra said it also wanted to participate in efforts to develop a helicobacter vaccine. On Wednesday it announced a deal with CSL, an Australian company, to collaborate in the research and development of a vaccine. T RADIO WAVES FDA gives approval on another treatment for enlarged prostate By The Associated Press WASHINGTON — Men suffering an enlarged prostate have another outpatient treatment option: a procedure using radio waves instead of the popular new microwave therapy. The Food and Drug Administration approved Vidamed Inc.'s transurethral needle ablation system, called TUNA, on Tuesday. As men age, the prostate gland enlarges until it can impede urination. In Vidamed's procedure, doctors thread needles into the prostate and use radio waves to heat them and kill the tissue. It will be difficult to choose between TUNA or microwave therapy, both similar in cost, safety and effectiveness, said Dr. John McConnell of the University of Texas. SUGGESTIONS? CALL SHERIDA WARNER, LIFE EDITOR, AT (913) 823-6363 OR 1-800-827-6363

What members have found on this page

Get access to

  • The largest online newspaper archive
  • 11,100+ newspapers from the 1700s–2000s
  • Millions of additional pages added every month

Try it free